1.0 Corporate Overview: A Legacy Reimagined
Established in 1993, Quality Pharmaceuticals (Pvt) Ltd. is embarking on an ambitious new chapter. Building on a solid three-decade foundation, the company is now being propelled by a dynamic team of young, energetic, and highly experienced professionals. This new leadership brings fresh perspectives from across pharmaceutical manufacturing, marketing, and sales, driving an unprecedented acceleration in all aspects of our business. Our mission is to leverage this legacy to achieve new heights in quality, product yield, market expansion, and global reach, transforming our potential into performance.
- Year Established : 1993 (A New Chapter Begins)
- Legal Status : Private Limited Company
- GMP Status : WHO-GMP Compliant
- Manufacturing License Valid Till: 10 December 2025
- The Drive : Accelerated Growth & Innovation
2.0 Our Guiding Philosophy: The New Vision
Our Vision:
To rapidly transform into a top-tier pharmaceutical company in Bangladesh and a respected name in international markets, known for cutting-edge quality, aggressive growth, and a dynamic approach to healthcare challenges.
Our Mission:
To accelerate the development and delivery of a diverse, high-quality medicine portfolio. We will achieve this through operational excellence, strategic market expansion, and leveraging the deep industry expertise of our new leadership team to outperform the growth of the past three decades.
Our Core Drivers:
- Ambitious Growth: We are aggressively pursuing expansion in product portfolio, manufacturing yield, and export footprints.
- Quality at Speed: Maintaining uncompromising quality while streamlining processes for faster time-to-market.
- Data-Driven Action: Utilizing modern analytics in sales, marketing, and production to make swift, informed decisions.
- Collaborative Innovation: Fostering a culture where cross-functional young leaders drive innovation in every department.
3.0 State-of-the-Art Manufacturing: Optimized for Performance
Our 12,607 sq. ft. facility in Kushtia is being energized with a focus on efficiency and scalability. We are optimizing our dedicated, segregated buildings for penicillin and non-penicillin products to maximize output without compromising safety.
Production Lines:
- Tablet & Capsule Sections: Utilizing modern compression and encapsulation equipment to increase production capacity and yield.
- Liquid & Sachet Section: Focused on streamlining processes for faster batch turnaround.
- Packaging: Upgrading blister and packaging lines to enhance speed and aesthetic appeal for competitive advantage.
Strategic Infrastructure:
- R&D & QC Labs: Empowering our Product Development Unit and QC labs to fast-track new product introductions and rigorous quality checks.
- Supply Chain: Implementing robust supplier management and inventory controls to ensure seamless production flow.
4.0 Uncompromising Quality Assurance: The Foundation of Growth
Our integrated Quality Management System (QMS) remains the non-negotiable core of our accelerated strategy. Our young leadership, steeped in modern quality systems, is reinforcing this framework to build unparalleled trust with new and existing partners.
Key Pillars of Our QMS:
- Advanced QC Labs: HPLC, UV Spectrophotometry, and microbiological testing ensure every product meets the highest standards.
- Agile Processes: Streamlined documentation and review processes without compromising compliance.
- Proactive Risk Management: Implementing modern Quality Risk Management (QRM) principles to anticipate and mitigate issues before they occur.
5.0 Our Expanding Product Portfolio
We are rapidly expanding our range of essential medicines. A selection of our prominent brands includes:
Anti-infectives
- Oromox® (Amoxicillin Capsule)
- Quflox® (Flucloxacillin Capsule)
- Oroflox® (Ciprofloxacin Tablet)
- Quamax® (Azithromycin Tablet)
Gastro-Intestinal
- Omilux-20® (Omeprazole Capsule)
- ECS-20® (Esomeprazole Capsule)
Pain & Inflammation Management
- Disodium TR® (Diclofenac Sodium Capsule)
- ASP-100® (Aceclofenac Tablet)
- Painfree® (Ketorolac Tromethamine)
An accelerated pipeline of new products is under development to serve unmet medical needs.
6.0 Aggressive Market Expansion
Our new commercial strategy is focused on dominating the domestic market while aggressively expanding our international footprint. We are revitalizing our retail and distribution network across Bangladesh and actively pursuing new export opportunities.
Current Export Markets:
- Afghanistan
- Sri Lanka
- Nepal
- Myanmar
- Yemen
Future Focus: Targeting entry into new, regulated markets in Asia, Africa, and beyond.